Clinical Trial Update: A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of brexpiprazole for Borderline Personality Disorder has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Borderline Personality Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-07-18